Benefit of PET in Esophageal Cancer Not Proven
|
By MedImaging International staff writers Posted on 04 Sep 2013 |
|
A new report claims that the patient benefits of positron emission tomography (PET) in esophageal cancer, either alone or in combination with computed tomography (CT), are not proven.
Researchers at the German Institute for Quality and Efficiency in Health Care (IQWiG; Köln, Germany) searched for studies that had examined the consequences of diagnostic interventions using PET or PET/CT, with regard to whether they were accompanied by perceptible improvements for patients (such as an increased of chances of survival or improved quality of life), or spared them unnecessary operations or further diagnostic interventions. The search for direct comparative intervention studies was unsuccessful, so that the question regarding the patient-relevant benefit of PET or PET/CT in esophageal cancer remains open.
The researchers also searched for studies in which the diagnostic accuracy and prognostic power of PET or PET/CT was compared with other examination methods. They found 48 studies relevant for diagnostic and prognostic accuracy, of which most examined the accuracy of primary staging. However, 19 studies directly compared PET with CT; the conclusions in favor of one or the two techniques could not be drawn, as either statistically significant difference was not shown or the data could not be interpreted with sufficient certainty. The report was published by IQWiG on August 20, 2013.
“A reliable conclusion on the diagnostic and prognostic accuracy of PET or PET/CT in restaging or recurrence diagnostics is therefore not possible,” concluded the researchers. “In particular the potential advantage of PET and PET/CT, which visualize metabolic activity, remains unclear versus morphologic imaging techniques such as CT or magnetic resonance imaging, which display anatomical structures.”
About 4,800 men and 1,400 women are newly diagnosed with esophageal cancer in Germany alone each year. The average age of disease onset is 65 years, and the 5-year survival rate is at best 20%. Many experts assume that an examination using PET or PET/CT is better able to evaluate how far a tumor has spread (staging) and whether it has responded to treatment (restaging); in addition, better detection of tumor recurrence ought to be possible.
Related Links:
German Institute for Quality and Efficiency in Health Care
Researchers at the German Institute for Quality and Efficiency in Health Care (IQWiG; Köln, Germany) searched for studies that had examined the consequences of diagnostic interventions using PET or PET/CT, with regard to whether they were accompanied by perceptible improvements for patients (such as an increased of chances of survival or improved quality of life), or spared them unnecessary operations or further diagnostic interventions. The search for direct comparative intervention studies was unsuccessful, so that the question regarding the patient-relevant benefit of PET or PET/CT in esophageal cancer remains open.
The researchers also searched for studies in which the diagnostic accuracy and prognostic power of PET or PET/CT was compared with other examination methods. They found 48 studies relevant for diagnostic and prognostic accuracy, of which most examined the accuracy of primary staging. However, 19 studies directly compared PET with CT; the conclusions in favor of one or the two techniques could not be drawn, as either statistically significant difference was not shown or the data could not be interpreted with sufficient certainty. The report was published by IQWiG on August 20, 2013.
“A reliable conclusion on the diagnostic and prognostic accuracy of PET or PET/CT in restaging or recurrence diagnostics is therefore not possible,” concluded the researchers. “In particular the potential advantage of PET and PET/CT, which visualize metabolic activity, remains unclear versus morphologic imaging techniques such as CT or magnetic resonance imaging, which display anatomical structures.”
About 4,800 men and 1,400 women are newly diagnosed with esophageal cancer in Germany alone each year. The average age of disease onset is 65 years, and the 5-year survival rate is at best 20%. Many experts assume that an examination using PET or PET/CT is better able to evaluate how far a tumor has spread (staging) and whether it has responded to treatment (restaging); in addition, better detection of tumor recurrence ought to be possible.
Related Links:
German Institute for Quality and Efficiency in Health Care
Digital X-Ray Detector Panel
Acuity G4
New
Prostate Cancer MRI Analysis Tool
DynaCAD Urology
X-ray Diagnostic System
FDX Visionary-A
Digital Radiographic System
OMNERA 300M
Latest Nuclear Medicine News
- Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
- Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
- Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
- Innovative PET Imaging Technique to Help Diagnose Neurodegeneration
- New Molecular Imaging Test to Improve Lung Cancer Diagnosis
- Novel PET Technique Visualizes Spinal Cord Injuries to Predict Recovery
- Next-Gen Tau Radiotracers Outperform FDA-Approved Imaging Agents in Detecting Alzheimer’s
- Breakthrough Method Detects Inflammation in Body Using PET Imaging
- Advanced Imaging Reveals Hidden Metastases in High-Risk Prostate Cancer Patients
- Combining Advanced Imaging Technologies Offers Breakthrough in Glioblastoma Treatment
- New Molecular Imaging Agent Accurately Identifies Crucial Cancer Biomarker
- New Scans Light Up Aggressive Tumors for Better Treatment
- AI Stroke Brain Scan Readings Twice as Accurate as Current Method
- AI Analysis of PET/CT Images Predicts Side Effects of Immunotherapy in Lung Cancer
- New Imaging Agent to Drive Step-Change for Brain Cancer Imaging
- Portable PET Scanner to Detect Earliest Stages of Alzheimer’s Disease
Channels
Radiography
view channel
AI Improves Early Detection of Interval Breast Cancers
Interval breast cancers, which occur between routine screenings, are easier to treat when detected earlier. Early detection can reduce the need for aggressive treatments and improve the chances of better outcomes.... Read more
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read more
MRI
view channel
Cutting-Edge MRI Technology to Revolutionize Diagnosis of Common Heart Problem
Aortic stenosis is a common and potentially life-threatening heart condition. It occurs when the aortic valve, which regulates blood flow from the heart to the rest of the body, becomes stiff and narrow.... Read more
New MRI Technique Reveals True Heart Age to Prevent Attacks and Strokes
Heart disease remains one of the leading causes of death worldwide. Individuals with conditions such as diabetes or obesity often experience accelerated aging of their hearts, sometimes by decades.... Read more
AI Tool Predicts Relapse of Pediatric Brain Cancer from Brain MRI Scans
Many pediatric gliomas are treatable with surgery alone, but relapses can be catastrophic. Predicting which patients are at risk for recurrence remains challenging, leading to frequent follow-ups with... Read more
AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read moreUltrasound
view channel.jpeg "Image: The AI-powered lung ultrasound tool outperformed human experts by 9% in diagnosing TB (Photo courtesy of Adobe Stock)")
AI-Powered Lung Ultrasound Outperforms Human Experts in Tuberculosis Diagnosis
Despite global declines in tuberculosis (TB) rates in previous years, the incidence of TB rose by 4.6% from 2020 to 2023. Early screening and rapid diagnosis are essential elements of the World Health... Read more
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read more
General/Advanced Imaging
view channel
CT-Based Deep Learning-Driven Tool to Enhance Liver Cancer Diagnosis
Medical imaging, such as computed tomography (CT) scans, plays a crucial role in oncology, offering essential data for cancer detection, treatment planning, and monitoring of response to therapies.... Read more
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
Imaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more
Industry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more